Literature DB >> 17499233

Association of serum levels of glycated albumin, C-reactive protein and tumor necrosis factor-alpha with the severity of coronary artery disease and renal impairment in patients with type 2 diabetes mellitus.

Lin Lu1, Li Jin Pu, Xue Wei Xu, Qi Zhang, Rui Yan Zhang, Jian Sheng Zhang, Jian Hu, Zheng Kun Yang, An Kang Lu, Feng Hua Ding, Jie Shen, Qiu Jin Chen, Sheng Lou, Dan Hong Fang, Wei Feng Shen.   

Abstract

OBJECTIVES: This study aimed to determine whether elevated serum levels of glycated albumin, high-sensitivity C-reactive protein (hsCRP) and tumor necrosis factor (TNF)-alpha were related to an increased risk for coronary artery disease (CAD) and renal insufficiency in patients with type 2 diabetes mellitus (T2DM). DESIGN AND METHODS: Serum levels of glycated albumin, hsCRP, TNF-alpha and blood glycosylated hemoglobin A1c (HbA1c) were measured in 317 consecutive patients with T2DM and 309 normal controls. Patients with T2DM were grouped based upon coronary angiographic findings (Group I: 151 patients with normal coronary arteries; Group II: 166 patients with significant coronary stenosis [>70% luminal diameter narrowing]) and renal functional status evaluated by estimated creatinine clearance (CrCl) (normal renal function group: 187 patients with CrCl >90 mL/min; mild renal insufficiency group: 103 patients with CrCl 60-90 mL/min; moderate renal insufficiency group: 27 patients with CrCl 30-60 mL/min). Multivariate analysis was performed to determine independent risk factors for CAD and renal insufficiency in patients with T2DM.
RESULTS: Serum levels of glycated albumin, hsCRP and TNF-alpha were significantly higher in Group II than in controls (P<0.01) and Group I (P<0.01). A significant difference was found in glycated albumin, hsCRP and TNF-alpha levels among diabetic patients with mild, moderate renal insufficiency and normal renal function (P<0.05). These biochemical measurements correlated significantly with number of diseased coronary vessels (P<0.01) and status of renal function (P<0.05). No difference existed in HbA1c levels between Group II and Group I, and among patients with various CrCL stages. Multivariate analysis revealed that male gender, old age and serum levels of glycated albumin, hsCRP, TNF-alpha and lipoprotein (a) were independent risk factors for CAD, and older age, hypertension and glycated albumin were for CrCl <60 mL/min in diabetes.
CONCLUSIONS: Increased serum levels of glycated albumin, hsCRP and TNF-alpha are associated with the presence and severity of CAD and renal impairment in patients with T2DM.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17499233     DOI: 10.1016/j.clinbiochem.2007.03.022

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  13 in total

Review 1.  Metrics Beyond Hemoglobin A1C in Diabetes Management: Time in Range, Hypoglycemia, and Other Parameters.

Authors:  Lorena Alarcon-Casas Wright; Irl B Hirsch
Journal:  Diabetes Technol Ther       Date:  2017-05       Impact factor: 6.118

2.  Increased C-reactive protein is associated with future development of diabetes mellitus in essential hypertensive patients.

Authors:  Chiung-Mei Weng; Chang-Hua Chou; Yao-Yi Huang; Chih-Chan Lin; Yen-Wen Liu; Wei-Chuan Tsai
Journal:  Heart Vessels       Date:  2010-07-31       Impact factor: 2.037

3.  Utility of glycated albumin for the diagnosis of diabetes mellitus in a Japanese population study: results from the Kyushu and Okinawa Population Study (KOPS).

Authors:  N Furusyo; T Koga; M Ai; S Otokozawa; T Kohzuma; H Ikezaki; E J Schaefer; J Hayashi
Journal:  Diabetologia       Date:  2011-09-27       Impact factor: 10.122

Review 4.  Type 2 diabetes and cardiovascular disease: Have all risk factors the same strength?

Authors:  Iciar Martín-Timón; Cristina Sevillano-Collantes; Amparo Segura-Galindo; Francisco Javier Del Cañizo-Gómez
Journal:  World J Diabetes       Date:  2014-08-15

5.  Effects of atorvastatin on progression of diabetic nephropathy and local RAGE and soluble RAGE expressions in rats.

Authors:  Lin Lu; Wen-Hui Peng; Wei Wang; Ling-Jie Wang; Qiu-Jing Chen; Wei-Feng Shen
Journal:  J Zhejiang Univ Sci B       Date:  2011-08       Impact factor: 3.066

Review 6.  Beyond HbA1c and glucose: the role of nontraditional glycemic markers in diabetes diagnosis, prognosis, and management.

Authors:  Christina M Parrinello; Elizabeth Selvin
Journal:  Curr Diab Rep       Date:  2014       Impact factor: 4.810

Review 7.  Glycated albumin (GA) and inflammation: role of GA as a potential marker of inflammation.

Authors:  H Vernon Roohk; Asad R Zaidi; Dimple Patel
Journal:  Inflamm Res       Date:  2017-10-11       Impact factor: 4.575

8.  Diabetes and cardiovascular disease.

Authors:  Zachary T Bloomgarden
Journal:  Diabetes Care       Date:  2011-03       Impact factor: 19.112

9.  Association of increased serum glycated albumin levels with low coronary collateralization in type 2 diabetic patients with stable angina and chronic total occlusion.

Authors:  Ying Shen; Lin Lu; Feng Hua Ding; Zhen Sun; Rui Yan Zhang; Qi Zhang; Zheng Kun Yang; Jian Hu; Qiu Jing Chen; Wei Feng Shen
Journal:  Cardiovasc Diabetol       Date:  2013-11-08       Impact factor: 9.951

10.  Diagnostic Utility of Serum Glycated Albumin for Diabetes Mellitus and Its Correlation With Hyperlipidemia.

Authors:  Sholhui Park; Wookeun Lee; Hae Sun Chung; Ki Sook Hong
Journal:  Ann Lab Med       Date:  2016-07       Impact factor: 3.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.